Commercial Launch Readiness
Preparing a presription drug diagnostic or medical device for commercial launch requires a deep understanding of its therapeutic area, competing products, and regulatory framework. Avalere experts have the skills and know-how to help your team navigate this critical step in product development.Overview
Product Launch Strategy
Commercial readiness requires impeccable attention to detail. Clear objectives and specific plans for navigating marketing, training, coding, reimbursement, and regulations set up a product for marketplace success.
The successful launch of a new drug, diagnostic, device, or combination product begins with a well-designed and well-executed commercial readiness plan. Designing such a plan requires an understanding of the relevant market segment, including regulations and product competition.
An Experienced Collaborator
At Avalere, we tap into our clinical, pharmaceutical, coding, reimbursement, and regulatory expertise to support your commercial readiness planning. Our seasoned experts will collaborate with you to develop and execute a plan tailored to the specific requirements of your product. We’ll work closely with you to develop a comprehensive readiness plan, and then pressure test it to ensure that you can weather even the toughest market scenarios. Our services include:
- Value proposition development
- Pricing and net pricing strategy
- Launch planning and readiness support
- Coding and reimbursement strategy and execution
- Coverage strategy development
- Customer-facing launch model build-out
- Contracting strategy development
Defining Market Access and Commercialization
Market access and commercialization encompasses the successive steps required to develop and support a life sciences product launch. During the R&D phase, treatment gap identification and the competitive environment must be properly assessed; in pre-launch, channel strategies and pricing defined. Finally, ongoing stakeholder engagement and evidence generation to support global product expansion are critical in the post-launch phase.
Engage An Avalere Expert Today.
Featured Commercial Launch Readiness Experts
Omar Hafez
Omar advises a range of clients on issues including supply chain, drug pricing, launch strategy, and oncology market analytics and planning.
Mark Gooding
Mark Gooding provides strategic guidance to life sciences clients on policy developments and reimbursement considerations.
Jessica Cortez
Jessica Cortez supports clients with exploration and analysis that span a variety of healthcare sectors and stakeholders.